TAAs are a cornerstone in the development of immunotherapies. These therapies harness the body's immune system to target and destroy cancer cells. Some approaches include:
Cancer Vaccines: Vaccines are designed to stimulate the immune system to recognize TAAs on cancer cells. Checkpoint Inhibitors: These drugs help to enhance the immune response by inhibiting proteins that suppress T-cell activity. Adoptive Cell Transfer: This involves engineering a patient's T-cells to express receptors that specifically recognize TAAs, such as in CAR-T cell therapy.
